Treatment of Chronic HCV in Special Populations: Thalassemia, Hemophilia, and Hemodialysis Patients-Reference-Cited by-同舟云学术

Treatment of Chronic HCV in Special Populations: Thalassemia, Hemophilia, and Hemodialysis Patients

Published:2012-08-31 Issue:4 Volume:11 Page:256-262
ISSN:1540-3416
Container-title:Current Hepatitis Reports
language:en
Short-container-title:Curr Hepatitis Rep

Author:

Alavian Seyed Moayed,Lankarani Kamran Bagheri,Sharara Ala I.

Publisher

Springer Science and Business Media LLC

Subject

Virology,Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s11901-012-0147-1.pdf

Reference83 articles.

1. Negro F, Alberti A. The global health burden of hepatitis C virus infection. Liver Int. 2011;31 Suppl 2:1–3.

2. Brown Jr RS, Gaglio PJ. Scope of worldwide hepatitis C problem. Liver Transpl. 2003;9(11):S10–3.

3. • Alavian SM, Tabatabaei SH, Mahboobi N. Epidemiology and risk factors of HCV infection among hemodialysis patients in countries of the Eastern Mediterranean Regional Office of WHO (EMRO): a quantitative review of literature. J Public Health (Oxf). 2011;19:191–203. An important regional epidemiologic report on HCV infection in hemodialysis patients.

4. Alavian SM, Ahmadzad Asl M, Lankarani KB, Shahbabaie MA, Bahrami Ahmadi A, Kabir A. Hepatitis C infection in the general population of Iran: a systematic review. Hepat Mon. 2009;9(3):211–23.

5. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13(17):2436–41.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Zinc Supplementation on Viral Response in Patients with Chronic Hepatitis C and Beta Thalassemia Major, A Pilot Study;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2014